Directorate Change
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your AREC notes
Cambridge, UK, 23 April 2024: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today's therapies to enable healthier lives, today announced that Susan Lowther has decided to step down from her role as Chief Financial Officer, Company Secretary and as a Board Director, to pursue new opportunities.
A search for Susan's successor is underway and her last day with Arecor is expected to be on the 22 July, to ensure an effective handover.
Sarah Howell, Chief Executive Officer of Arecor, said: "On behalf of the Board and all at Arecor, I want to thank Susan for her contributions over the past five years, in our transition to a public company and growth as a business. We wish her every success in her future plans."
Susan Lowther, Chief Financial Officer of Arecor, said: "I am proud to have been Arecor's first Chief Financial Officer and of our achievements as a business, and believe the Company is well placed for further growth. I will watch the future progress with interest."
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.